Proteomics signs deal for distribution of PromarkerD in Italy – Biotech Dispatch
“Previously we focused on the more sophisticated mass spectrometry test, but the release of this easy-to-use, higher throughput immunoassay platform opens up many more market opportunities,” he [Managing Director Dr. Richard Lipscombe] said.“
“The immunoassay (ELISA) technology allows hundreds of blood samples to be analysed quickly as a part of a panel of routine blood tests.”
Article: Proteomics signs deal for distribution of PromarkerD in Italy